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 1 
A systematic review on reporting outcomes and outcome measures in trials on synthetic 1 
mesh procedures for pelvic organ prolapse. Urgent action is needed to improve quality of 2 
research.   3 
 4 
Abstract  5 
The use of synthetic mesh in pelvic organ prolapse surgery is being closely scrutinized 6 
because of serious concerns regarding life-changing complications such as erosion, pain, 7 
infection, bleeding, dyspareunia, organ perforation and urinary problems. Randomized 8 
trials and their syntheses in meta-analysis offer a unique opportunity to assess efficacy 9 
and safety. However, outcomes and outcome measures need to be consistently selected, 10 
collected, and reported across randomized trials to be effectively combined in systematic 11 
reviews.  12 
Aims  13 
We evaluated outcome and outcome measure reporting across randomized controlled 14 
trials on surgical interventions using synthetic mesh for pelvic organ prolapse.  15 
Methods 16 
Systematic review of randomized controlled trials using synthetic mesh for the treatment of 17 
pelvic organ prolapse. The selected studies were evaluated using Jadad and MOMENT 18 
criteria. Outcomes and outcome measures were systematically identified  and categorized.  19 
Results 20 
Seventy-one randomized trials were included. Twenty-four different types of mesh were 21 
identified. Included trials reported 110 different outcomes and 60 outcome measures. 22 
Erosion (40 trials, 78,43%), pain (29 trials, 56,86%), bleeding (31 trials, 60,78%) and 23 
dyspareunia (25 trials, 49,02%) were the most frequently reported outcomes. The longest 24 
follow up was 74 months.  25 
Conclusions 26 
 2 
Most randomized trials evaluating surgical interventions using synthetic mesh for pelvic 27 
organ prolapse failed to report on clinically important outcomes and to evaluate efficacy 28 
and safety over the medium- and long-term. Developing and implementing a minimum 29 
data set, known as a core outcome set, in future vaginal prolapse trials could help address 30 
these issues.   31 
 32 
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Surgical interventions for the treatment of pelvic organ prolapse have been performed 54 
extensively . The International Urogynecological Association and the International 55 
Continence Society have defined mesh as ‘a (prosthetic) network fabric or structure used 56 
in general for prolapse surgery with synthetic materials’. [1] The Food and Drug 57 
Administration has recently reclassified synthetic mesh as a high-risk device. [2] Our 58 
specialty has failed many women with pelvic organ prolapse and has not lived up to one of 59 
the oldest medical principles “above all, do no harm”.  60 
 61 
Randomized controlled trials and their syntheses in meta-analysis should offer a unique 62 
opportunity to assess the efficacy and safety of synthetic mesh for pelvic organ prolapse 63 
procedure. Although there is often no hypothesis concerning harms in trials, safety 64 
outcomes should be collected and reported as secondary outcomes. Unfortunately, the 65 
collection and reporting of safety has drawn limited attention: for example, the 66 
Consolidated Standards of Reporting Trials (CONSORT) statement published an 67 
extension for harm reporting, five years after the original statement. Without high-quality 68 
data relating to the trade-offs between benefits and harms suboptimal decisions may have 69 
been made.  70 
 71 
The International Urogynecologial Association and the International Continence Society 72 
has engaged with standardizing the mesh complication definitions:  73 
1. Exposure: Condition of displaying, revealing, exhibiting or making accessible;  74 
2. Extrusion: Passage gradually out of a body structure or tissue; and 75 
3. Perforation: Abnormal opening into a hollow organ or viscus [1] 76 
The next challenge is to address unwarranted, unhelpful and often confusing variation in 77 
outcome selection, collection and reporting. The development and use of a core outcome 78 
 4 
set would help to address this challenge. The first step in core outcome set development 79 
requires an evaluation of outcome and outcome reporting across published randomized 80 
trials. CHORUS is an International Collaboration for Harmonizing Outcomes, Research 81 
and Standards in Urogynaecology and Women’s Health (http://i-chorus.org), aiming to 82 
address such issues in all areas of urogynaecology/female pelvic medicine and 83 
reconstructive surgery. We have recently published relevant papers on childbirth trauma 84 
and anterior prolapse surgery. [3, 4]  85 
 86 
Therefore, the aim of the present study was to assess the consistency in outcome and 87 
outcome measure reporting among randomized trials evaluating surgical interventions 88 
using synthetic mesh for pelvic organ prolapse.  89 
  90 
Material and methods 91 
This systematic review has been undertaken by CHORUS: An International Collaboration 92 
for Harmonizing Outcomes, Research and Standards in Urogynecology and Women’s 93 
Health and has been registered with the Prospective Register of Systematic Reviews 94 
(PROSPERO), registration number CRD42017062456. A protocol including explicitly 95 
defined objectives, study selection criteria, and data extraction methods was developed. 96 
Ethical approval for this study was not required.  97 
 98 
Search strategy  99 
The search strategy was performed in accordance to PRISMA criteria. The review was 100 
undertaken by searching the Cochrane Central register of Controlled Trials (CENTRAL),  101 
EMBASE and MEDLINE, from their inception to June 2018 using MeSH words pelvic 102 
organ prolapse, vaginal prolapse, bladder prolapse, cystocele, bowel prolapse, rectocele, 103 
enterocele, uterine prolapse and vault prolapse. Two researchers independently screened 104 
 5 
each potentially relevant record on the basis of its title and abstract, and subsequently 105 
reviewed the full text of each selected study to assess eligibility. Discrepancies in initial 106 
screening between the two researchers were resolved by consensus.  107 
 108 
We included randomized controlled trials evaluating surgical interventions using synthetic 109 
mesh for pelvic organ prolapse in English language. Non-randomized studies, 110 
observational studies, and case reports were excluded.  111 
 112 
Two researchers independently extracted study characteristics, including methodological 113 
quality and quality of outcomes, interventions and reported outcomes. Again, any 114 
discrepancies between the researchers were resolved by consensus among the authors.  115 
 116 
The methodological quality of the selected studies was evaluated according to modified 117 
Jadad score. This is a 5-point scale that scores 1 point for each description: 118 
randomisation; adequate method for randomisation; blinded trial described; adequate 119 
method for blinding and if the trial accounts for the patients selected. [5] The outcome 120 
quality was scored according to the MOMENT criteria (Management of otitis media with 121 
effusion in cleft palate score system), in a 6-point scale. It sums 1 point for the state of a 122 
primary outcome; if the primary outcome is defined for reproducible measures; the state of 123 
a second outcome; if the second outcome is defined as for reproducible measures; if the 124 
choice of outcome is explained and if the methods used are designed to improve 125 
appropriately the quality of measures. [6] High quality was determined for studies that 126 
reached score 4 or more in these criteria. 127 
 128 
An inventory of outcomes reported in each study was developed. They were then 129 
organized into thematic domains by the researchers.  130 
 6 
 131 
Articles that used the same population and intervention (secondary analyses) were defined 132 
as follow up studies and duplicated outcomes for the same population were considered 133 
only once. Year and Journal of publication were also listed and Journal impact factor was 134 
reported according to Thomson Reuters’ (NY, USA) citation reports for obstetrics and 135 
gynecology. Descriptive statistics were used to characterize the trials included in the 136 
review, mapping outcomes and their methods of definition or measurement across 137 
included trials. These data were managed in Excel 2013 (Microsoft Corporation, WA, USA)  138 
 139 
Results 140 
In total, 2567 titles and abstracts were screened, and 234 potentially relevant studies were 141 
examined in detail (Figure 1). Fifty-one randomized trials met the inclusion criteria. Twenty 142 
published follow-up studies were included. Quality of studies and outcomes are presented 143 
in Table 1. Year of publication ranged from 2000-2017 in vaginal and 2003-2015 in 144 
abdominal studies. The mean JADAD and MOMENT score among all studies were 3.59 145 
and 4.63 respectively. (Table 1) Description of interventions and mesh used are displayed 146 
in Tables 2 and 3. The longest patient follow up was reported as 74 months. The mean 147 
follow up was 19.34 months.  148 
 149 
Reported outcomes 150 
In total, 110 different outcomes were identified. They were divided into domains (adverse 151 
events, clinical effectiveness, efficacy and cost effectiveness) and described in Table 4. 152 
The most common outcomes were mesh exposure (40 studies, 78.43%), operative time 153 
(38 studies, 74.50%), blood loss and hospital stay (32 studies each, 62.74%).  154 
 155 
Twenty-four different meshes were described in the included studies. Studies on vaginal 156 
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meshes reported more voiding symptoms and dysfunction (21 times documented in the 157 
studies) than the ones on abdominal approach (6 times). Stress urinary incontinence was 158 
the most frequently reported outcome for urinary incontinence (26 studies, 50.98%), 3 159 
times more in vaginal than abdominal route. Also, vaginal studies presented more on 160 
sexuality in women after the procedure, and dyspareunia was 4.2-fold more cited in 161 
vaginal than in abdominal mesh studies (21 and 5 studies, respectively). 162 
 163 
Mesh-related outcomes 164 
In relation to mesh, there were 20 different outcomes. Mesh related outcomes were much 165 
more frequently reported in studies on vaginal mesh compared to those on abdominal 166 
insertion of mesh (87 times and 25 times respectively). Emphasis on mesh excision, mesh 167 
exposure and mesh removal were much more often observed in studies evaluating 168 
prolapse repairs using mesh via vaginal route.  169 
 170 
A high number of studies presented data as length of hospital stay (32 studies, 62.74%) 171 
and operative time (38 studies, 74.50%). These outcomes were more frequently reported 172 
than bladder injury (20 studies, 39.21%) and abdominal and pelvic pain (30 studies, 173 
58.82%).  174 
 175 
Variations in outcomes measures 176 
Sixty outcome measures are listed in Table 5. Visual Analogue Scale (VAS) was used in 177 
32% of the studies for different purposes (pain, patient satisfaction, degree of bother). Only 178 
72.54% of the studies reported POP-Q measurement for treatment effectiveness 179 
evaluation. Baden-Walker scale was reported in 2 studies. Eighteen studies described 180 
physical examination as a part of the evaluation (35.29%).  181 
 182 
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A few studies reported on the amount of intraoperative bleeding, but there was no variation 183 
on this measurement. Only in one study the weighing of towels was used to measure 184 
bleeding, while 6 studies used hemoglobin or haematocrit.  185 
 186 
Efficacy outcomes 187 
Outcomes reported efficacy as “cure” or “success” (27 studies, 52.94%) or “failure” (10 188 
studies, 19.60%). Some studies evaluated success or failure only anatomically, while 189 
others included patient satisfaction. Some used the term ‘cure’ to show optimal results, 190 
making the anatomical evaluation variable between optimal and satisfactory success 191 
outcome. POP-Q assessment was used in all studies to evaluate outcome of surgery 192 
(success if POP-Q < stage 2, failure if POP-Q ≥ stage 2). A reported measure of success 193 
was the lack of prolapse recurrence indirectly evaluated as no need for operation.  194 
 195 
Quality of life evaluation 196 
Quality of life was assessed by validated questionnaires and scores in the majority of 197 
studies. All the questionnaires used are listed in Table 4. We identified 34 different tools, 198 
and questionnaires being part of another questionnaire (as CRADI belongs to PFDI). The 199 
most commonly used questionnaire was the Pelvic Organ Prolapse/Urinary Incontinence 200 
Sexual Questionnaire (PISQ-12), featured 14 times (28%), followed by Pelvic Floor 201 
Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ), identified in 11 202 
(22%) and 10 (20%) studies, respectively.   203 
  204 
Discussion 205 
 206 
Summary of main findings 207 
 208 
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Our systematic review demonstrated a wide variation both in reported outcomes and 209 
outcome measures in most trials on POP surgery. Among the reported outcomes, mesh-210 
related, intraoperative data and complications and anatomic results were the most variable 211 
ones. Post-operative urinary symptoms and functional outcomes were more extensively 212 




It is clear that the identified variations in outcomes would preclude comparisons and 217 
combinations of the findings in a meta-analysis. In addition, these wide variations may be 218 
responsible at least partly for the inconsistent and often conflicting evidence and 219 
controversies around mesh research evidence.  220 
 221 
Variations in outcomes may be secondary to several inherent methodological factors in 222 
surgical trials, including surgical techniques, surgeon’s skills, type of instruments and 223 
material used as well as demographic characteristics of the patients. However, 224 
superimposing these often unavoidable variations with additional heterogeneity based on 225 
the selection of outcomes and outcome measures, will inevitably result in an unnecessarily 226 
compounded overall heterogeneity of the primary trials.  227 
 228 
Certainly, the results may also be somehow affected by the significant and rapid changes 229 
in reconstructive pelvic surgery which have occurred in the last two decades, moving 230 
towards minimally invasive surgery (laparoscopic/robotic). The outcomes reflect also 231 
surgical routes and techniques. Studies on laparoscopic procedures may report outcomes 232 
related to length of hospitalization more than those on open abdominal techniques.   233 
 234 
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Strengths and limitations 235 
 236 
To our knowledge, this is the first systematic review evaluating the quality of randomized 237 
controlled trials and analyzing these outcomes and outcome measures. We followed a 238 
rigorous search strategy and the assessment of the studies was as standardized as 239 
possible following the methodology of previous publications in this field. [3, 7]  240 
 241 
However, as most studies of this type, we acknowledge the limitation of missing out 242 
reported outcomes from non-randomized trials which were excluded from our study. The 243 
rationale for analyzing outcomes of randomized and non-randomized studies separately 244 
follows the conventional approach of performing meta-analysis and systematic reviews of 245 
randomized and non-randomized studies separately. Moreover,only studies in English 246 
language were included as this criterion was predefined in the present systematic review. 247 
One of the main reasons involves possible complexities arising from terminology and 248 
definitions in the area of pelvic medicine across different languages, which would possibly 249 
influence the taxonomy and classifications of outcomes in thematic groups, without adding 250 
much essential weight into our findings given that the vast majority of randomized 251 
controlled trials would be in English language.  252 
 253 
Categorization of outcomes and outcome domains can be undertaken through different 254 
approaches and therefore interpretation of the different groups of outcomes may vary. We 255 
did not differentiate specific outcomes to studies on specific anatomical compartment as 256 
our aim was to have a uniform approach to all prolapse trials using mesh and ideally focus 257 




Recommendations  261 
 262 
While the development of Core Outcome sets in the area of POP is still under way, we 263 
would recommend as an interim consensus the use of a short list of the most commonly 264 
reported outcomes based on our findings as a minimum set. These outcomes and 265 
outcome measures could be the three or four most commonly reported ones in each 266 
domain, including a separate domain specific for mesh. Future studies should use 267 
validated questionnaires for Quality of Life, such as Pelvic Floor Distress Inventory (PFDI), 268 
Pelvic Floor Impact Questionnaire (PFIQ) and Pelvic Organ Prolapse/Urinary Incontinence 269 
Sexual Questionnaire (PISQ). All patients after a prolapse surgery with mesh 270 
augmentation should undergo physical examination and POP-Q measurement ideally in a 271 
long-term follow up assessment, which would facilitate the establishment of the definition 272 
of anatomical success or failure of each procedure. 273 
 274 
Long term follow-ups for prolapse interventions using mesh have been recommended. The 275 
post-operative interval to law suits is 5.3 years for prolapse treatment with synthetic mesh. 276 
In patients treated with sling tapes concomitantly to prolapse the interval is 4.8 years. [2] 277 
 278 
The establishment of an interim minimum set of core outcomes and outcome measures 279 
based on this review may well differ from the final set as patient involvement as well as a 280 
wider stakeholder participation is essential in this development and may influence the 281 
agreed core outcome sets. 282 
  283 
Conclusion  284 
 285 
Interventions for pelvic organ prolapse using synthetic mesh require additional attention for 286 
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complications and postoperative symptoms and outcomes. They are not free from failure 287 
and recurrence. Vaginal and abdominal procedures may have different success and failure 288 
rates.  Their outcomes should be comparable. The development of core outcome sets for 289 
these procedures will facilitate the design of future studies and promote high quality 290 
evidence that will advise patient centered clinical practice.  291 
 292 
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